MYO1G and acute lymphoblastic leukemia: Interestingly when we classified patients according to the risk, we found that myo1g was upregulated in high-risk patients (***P < 0.001, and was Not Significant p = 0.06 in Standard risk patients) Figure 1D, indicating that Myo1g could be associated with high-risk patients of pediatric ALL.